Serotonin News and Research

Latest Serotonin News and Research

Zebrafish offers clue to alleviate gastrointestinal distress related to autism

University of Miami researchers have discovered a clue in the humble zebrafish's digestive tract that, one day, could help people on the autism spectrum alleviate one of the most common yet least studied symptoms of their disorder: gastrointestinal distress.

7 Feb 2019

Making the Most of Microdialysis for Neurotransmitter Analysis

Martin Eysberg provides an introduction to the ALEXYS Neurotransmitter Analyzer, an extremely precise UHPLC-EC detector for neurotransmitter analysis.

From Antec Scientific 6 Feb 2019

UC study reveals most effective medication for treating pediatric anxiety

Researchers from the University of Cincinnati (UC) examined common medications prescribed for children and adolescents with anxiety disorders, to determine which are the most effective and best-tolerated.

1 Feb 2019

Salk researchers pin down why some patients don't respond to common antidepressants

The most commonly prescribed antidepressants, selective serotonin reuptake inhibitors, lift the fog of depression for many people. But for around a third of people with major depressive disorder, SSRIs don't make much of a difference.

1 Feb 2019

Serotonin may help the brain execute instantaneous behaviors in emergency situations

Known for its role in relieving depression, the neurochemical serotonin may also help the brain execute instantaneous, appropriate behaviors in emergency situations, according to a new Cornell study published Feb. 1 in Science.

1 Feb 2019

Exercise-induced muscle changes could help boost mood in older adults, study suggests

New research suggests that exercise-induced muscle changes could help boost mood in older adults. The study is published ahead of print in the American Journal of Physiology--Cell Physiology.

31 Jan 2019

Patients taking anti-depressants more likely to develop gastrointestinal bleeding

Patients taking anti-depressant medications classified as selective serotonin reuptake inhibitors are 40 percent more likely to develop severe gastrointestinal bleeding, particularly when they also use common over-the-counter pain relievers, according to a research review in the Journal of the American Osteopathic Association.

31 Jan 2019

Reassuring findings on the link between antidepressants and fertility

Based on limited research, there's no strong evidence that selective serotonin-reuptake inhibitors (SSRIs) - the most widely used class of antidepressants - have an adverse impact on fertility, according to a paper in the Harvard Review of Psychiatry.

25 Jan 2019

Mutant mice administered with cocaine failed to exhibit hyperactivity, shows study

Cocaine is a highly addictive psychostimulant that induces complex molecular, cellular and behavioral responses. Despite various approaches and years of pre-clinical studies, effective, mechanism-based therapies to assist with cocaine misuse and dependence are still sorely lacking.

16 Jan 2019

Using Assay Kits and Dyes to Advance Cell Biology Research

In this interview, Richard Delle Bovi highlights live cell ability of the CELLESTIAL® analysis kit from Enzo Life Sciences and its applications in cell biology.

From Enzo Life Sciences, Inc. 2 Jan 2019

Researchers aim to improve cognition, reverse weight gain in schizophrenia

Aerobic exercise can improve the size and function of the brain, and now investigators want to know if it can also improve cognitive function in patients with schizophrenia who struggle with memory and attention problems.

19 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Caffeine plus another compound in coffee may fight Parkinson’s disease

Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson's disease and Lewy body dementia - two progressive and currently incurable diseases associated with brain degeneration.

10 Dec 2018

Discovery would help specify role of genetics in the development of neuropsychiatric disorders

Neurobiologists from I.M. Sechenov First Moscow State Medical University confirmed that stress in early age affects the mice with activated and deactivated CDH13 gene in different ways.

27 Nov 2018

Human drugs alter cricket personality

Crickets that are exposed to human drugs that alter serotonin levels in the brain are less active and less aggressive than crickets that have had no drug exposure, according to a new study led by researchers from Linköping University. The findings have been published in Scientific Reports.

18 Nov 2018

Researchers for first time view serotonin activating its receptor using high-powered microscopes

Serotonin receptors are common drug targets in the treatment of pain, gastrointestinal dysfunctions, and mood disorders yet little is known about their three-dimensional structure.

2 Nov 2018

Drug combination not more effective in improving depression than single antidepressant

Psychiatrists and GPs increasingly combine mirtazapine with an SSRI (selective serotonin reuptake inhibitor) or SNRI (serotonin-noradenaline reuptake inhibitor) antidepressant for patients whose depression does not respond to a single antidepressant.

1 Nov 2018

Researchers develop new strategy in the search for psychoactive drugs

Researchers at the University of Zurich and Harvard University have developed a new strategy in the search for psychoactive drugs.

1 Nov 2018

LSD changes the communication patterns between the brain regions, shows study

LSD changes the communication patterns between regions of the brain, a new study by researchers of the University of Zurich and Yale University shows.

30 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Serotonin News and Research

Latest Serotonin News and Research

Zebrafish offers clue to alleviate gastrointestinal distress related to autism

Making the Most of Microdialysis for Neurotransmitter Analysis

UC study reveals most effective medication for treating pediatric anxiety

Salk researchers pin down why some patients don't respond to common antidepressants

Serotonin may help the brain execute instantaneous behaviors in emergency situations

Exercise-induced muscle changes could help boost mood in older adults, study suggests

Patients taking anti-depressants more likely to develop gastrointestinal bleeding

Reassuring findings on the link between antidepressants and fertility

Mutant mice administered with cocaine failed to exhibit hyperactivity, shows study

Using Assay Kits and Dyes to Advance Cell Biology Research

Researchers aim to improve cognition, reverse weight gain in schizophrenia

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Caffeine plus another compound in coffee may fight Parkinson’s disease

Discovery would help specify role of genetics in the development of neuropsychiatric disorders

Human drugs alter cricket personality

Researchers for first time view serotonin activating its receptor using high-powered microscopes

Drug combination not more effective in improving depression than single antidepressant

Researchers develop new strategy in the search for psychoactive drugs

LSD changes the communication patterns between the brain regions, shows study

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Serotonin News and Research

Latest Serotonin News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in